In HFmrEF or HFrEF, digitalis glycosides reduce a composite of CV death or worsening HF event vs. placebo at a median 36 to 37 mo
- DOI
- 10.7326/annals-26-03020-jc
- Published
- 2026-09
- Container
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.7326/annals-26-03020-jc,
title = {In HFmrEF or HFrEF, digitalis glycosides reduce a composite of CV death or worsening HF event vs. placebo at a median 36 to 37 mo},
author = {Dmitry Abramov and Harriette Van Spall and Unknown},
year = {2026},
journal = {Annals of Internal Medicine},
doi = {10.7326/annals-26-03020-jc},
url = {https://doi.org/10.7326/annals-26-03020-jc}
}RIS
TY - JOUR TI - In HFmrEF or HFrEF, digitalis glycosides reduce a composite of CV death or worsening HF event vs. placebo at a median 36 to 37 mo AU - Dmitry Abramov AU - Harriette Van Spall AU - Unknown PY - 2026 JO - Annals of Internal Medicine DO - 10.7326/annals-26-03020-jc UR - https://doi.org/10.7326/annals-26-03020-jc ER -
APA
Abramov, D., Spall, H. V., & Unknown (2026). In HFmrEF or HFrEF, digitalis glycosides reduce a composite of CV death or worsening HF event vs. placebo at a median 36 to 37 mo. Annals of Internal Medicine. https://doi.org/10.7326/annals-26-03020-jc
Source records
- crossref · retrieved 2026-09-25T19:31:46.667Z